John Delacourt serves as Deputy General Counsel of the Biotechnology Innovation Organization (BIO), where he works with BIO’s staff to lead legal support for commercial operations and with its membership to ensure patient access to life-saving medicines, bring down barriers to innovation, and promote policies conducive to advances in agriculture and environmental science. Prior to joining BIO, he served as Chief Legal Officer & Head of Global Policy for the Plasma Protein Therapeutics Association (PPTA). While at PPTA, John led the association’s litigation defense and regulatory compliance efforts in both the United States and Europe. He also served as legal advisor to PPTA’s principal governing bodies, including on such issues as drug shortage preparedness, discriminatory labeling practices, and secure handling of biometric data. Prior to joining PPTA, he practiced at major law firms in Washington, D.C. and New York. He also served in senior roles at the Federal Trade Commission, including as Chief Antitrust Counsel of the FTC’s Office of Policy Planning. John is a graduate of Georgetown University and Harvard Law School.